Abstract

COVID-19 ASSOCITED MUCORMYCOSIS

Priyanka S. Nilangekar*, Dr. Sameer Shafi, Monika D. Khichade, Aishwarya S. Gandhle, Sushil S. Kore and Mohini A. Gurav

ABSTRACT

Mucormycosis, conjointly referred as “Black Fungus”, could be a new cause for worry within the current Coronavirus sickness 2019 (covid-19) pandemic. Mucormycosis is devasting because of its high rate of morbidity and mortality that could be a nice reason for concern. Mucormycosis, in general, affects upset patients as well as diabetic, folks with malignancies, organ and somatic cell transplants and other people affected with pandemic diseases like covid-19. Designation of Mucormycosis is usually delayed either because of clinical complications or misdiagnosed as symptoms of different diseases, particularly covid-19. This might delay the treatment protocol which ends within the failure of treatment. Fatality rate because of secondary infections in covid-19 patients with uncontrolled diabetics and WHO are on steroid medical care will presently reach 100 present if designation and treatment doesn‟t happen on timely basis. Risk of Mucormycosis isn‟t simply in immunological disorder patients; however immunocompetent folks with late designation are vulnerable to infection. See able of this, we have a tendency to gift a comprehensive review on risks of Mucormycosis in upset and immunocompetent patients‟ lightness the medical specialty, kinds of Mucormycosis, immune reaction against order Mucorales, difficulties in designation and challenges in treatment of Mucormycosis, with stress on covid19 associated Mucormycosis. Significantly, we‟ve mentioned the precautions and care to effectively manage Mucormycosis in upset and immunocompetent patients. Thus,

Keywords: current review helps clinicians in understanding numerous risk factors in each upset (especially covid-19 patients) and immunocompetent patients that is vital in managing Mucormycosis in current covid-19 pandemic.